Biogen, in Reversal, Will Seek FDA OK for Alzheimer’s Drug After Further Analysis

  • 📰 WSJ
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

Biogen plans to pursue approval for an early Alzheimer’s treatment, after pulling the plug on phase 3 studies of the drug this year

Change in plans follows an analysis of a larger dataset from studies of aducanumab; share price surges on the newsBiogen Inc. said it plans to pursue regulatory approval for aducanumab, an investigational treatment for early Alzheimer’s disease, after pulling the plug on phase 3 studies of the drug earlier this year.

Shares of Biogen surged 40% in premarket trading, putting the company on track to add more than $16 billion in market value. When the company and partner Eisai & Co. in March said they would terminate the late-stage studies, Biogen lost about $18 billion in market value.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

no medical innovations out of China? didn't think so. Trump2020

We shudder to think of this drug's monthly price tag should it be approved for the market and who is going to pay for it.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves premarket: Biogen, Under Armour, P&G, Hasbro & moreThese are the stocks posting the largest moves before the bell.
Source: CNBC - 🏆 12. / 72 Read more »

Biogen resurrects Alzheimer's drug; shares jump 35%Biogen Inc revealed surprise plans to seek U.S. regulatory approval for its Alzh...
Source: Reuters - 🏆 2. / 97 Read more »

Biogen resurrects Alzheimer's drug; shares jump 35%Biogen Inc revealed surprise plans to seek U.S. regulatory approval for its Alzh...
Source: Reuters - 🏆 2. / 97 Read more »

FDA OKs Diabetes Drug for Type 2 Heart Failure RiskThe FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it. The cost will be $5000
Source: WebMD - 🏆 709. / 51 Read more »

FDA approves AstraZeneca diabetes drug for treating heart failure riskAstraZeneca's diabetes drug Farxiga has been approved for use in the United...
Source: Reuters - 🏆 2. / 97 Read more »

Analysis | How Democrats Can Turn Immigration Into Trump’s KryptoniteAnalysis: There’s a story about immigration that can unite the country, not divide it further Odd how Republicans pretend to respect the flag they crap on. :-) How about the fact that almost everyone is a descendant of immigrants. A large portion of us are descendants of immigrants who came here before any immigration laws. Immigration is what made the United States great, period. After seeing Bowling for Columbine on MSNBC last night, I think this country ought to go on therapy. We are all scared shitless. It has been induced by media.
Source: politico - 🏆 381. / 59 Read more »